Security key
03969K108
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)
CUSIP: 03969K108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 127,080,415
- Total 13F value
- $1,781,069,063
- Share change
- +2,056,772
- Put/Call ratio
- 53%
- SEC-reported price per share
- $14.02
- Number of holders
- 228
- Value change
- +$21,637,125
- Number of buys
- 122
- Number of sells
- 110
- Shares outstanding
- 125,896,702
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
228
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences VII...
Disclosed value leader
MONTANOVA CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5
13F
Highest disclosed value: $178,655,376
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MONTANOVA CAPITAL, LLC has the largest disclosed position value at $178.66M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MONTANOVA CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
Frazier Life Sciences VIII, L.P.
$31.26M
ORBIMED ADVISORS LLC
$1.47M
MONTANOVA CAPITAL, LLC
$178.66M
JENNISON ASSOCIATES LLC
$177.68M
Rubric Capital Management LP
$171.52M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$31,255,566
8,827,261 shares
|
— | 24 Oct 2023 |
| ORBIMED ADVISORS LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,469,935
415,142 shares
|
— | 24 Jun 2022 |
| MONTANOVA CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$178,655,376
11,422,978 shares
|
— | 31 Mar 2025 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
—
denominator unverified
|
$177,684,084
11,360,875 shares
|
— | 31 Mar 2025 |
| Rubric Capital Management LP |
13F
Company
|
—
denominator unverified
|
$171,518,750
10,966,672 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$139,076,152
8,892,337 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
228
Shares
127,080,415
Rows available
228
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
239
Q2 2025 holders
228
Holder diff
-11
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend